FINANCIAL NEWS

ASX Winners And Losers Of Today – 25-11-25

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 25 2025


Picking A Lane: Car Platform Carma’s ASX Listing

Used car enterprise Carma listed earlier this month, raising $100m via its IPO

Nov 25 2025


Weekly Update On LICs & LITs – 25-Nov-2025

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 25 2025


4DMedical Poised For A Recovery

Michael Gable of Fairmont Equities notes 4DMedical shares retraced from a new October high and the bounce supports a move higher

Nov 25 2025


Nufarm’s Growing Optimism

Nufarm posted a better than feared FY25 result, surprised by deciding to retain its Seeds business, and has optimistic growth targets for FY26

Nov 25 2025


Citi rates AX1 as Downgrade to Neutral from Buy

After a detailed review, Citi downgraded Accent Group to Neutral from Buy, noting risk from weak lifestyle sales. Limited further cost flexibility, and elevated key-person risk are expected to outweigh improving comps and stable margins.

Target trimmed to $1.08 from $1.83.

Previous commentary from the broker follows:

In an early assessment, Citi describes today's Accent Group AGM update as sharply weaker than expected, with year-to-date like-for-like sales down -0.4% vs consensus of 2.15%. Gross margins were also -160bps lower, against expectations for a rise.

The broker notes FY26 guidance relies on a 2H26 recovery in both sales and margins, both difficult to justify.

Management cut 1H26 earnings (EBIT) guidance to $55-60m (from around an implied $80.7m), around -28% below the consensus forecast. FY26 EBIT of $85-95m was a -23% downgrade at the midpoint, observe the analysts.

While October like-for-like sales lifted to 0.4%, Citi doubts the market will place any weight on this, given the scale of the guidance downgrade.

Bell Potter rates GTK as Buy

Bell Potter notes Gentrack Group's FY25 result was broadly in line with consensus, delivering revenue of NZ$230.2m and EBITDA of NZ$27.8m. This compared with the broker's forecast of NZ$233m and NZ$29m, respectively.

Strong comments on the project pipeline sparked a solid share price lift and improved confidence in near-term contract wins and growth, the broker highlights. The company stated landing 3-4 of the current pipeline opportunities would underpin strong FY27 growth.

EPS forecast for FY26 trimmed by -1% but FY27 lifted by 2%. Target rises to $11.00 from $9.80 on DCF roll-forward. 

Buy retained.

Macquarie rates VAU as Outperform

Following a 6.5-for-1 share consolidation, Macquarie's target price for Vault Minerals is $6.50 from $1.00.

Outperform maintained.

Click here to see full report market arrow icon

ANALYSIS & DATA

FNARENA'S MARKET CONSENSUS FORECASTS

To display the stock analysis for a company please enter the company code:

ANZ | ANZ GROUP HOLDINGS LIMITED

Abbreviated format - see the full version here


LAST PRICECHANGE +/-CHANGE %VOLUME

$34.94

24 Nov
2025

market green arrow 0.040

OPEN

$35.00

market green arrow 0.11%

HIGH

$35.24

7,000,039

LOW

$34.72

TARGET
$33.515-4.1% downside
Franking for last dividend paid out: 70%
FNARENA'S MARKET CONSENSUS FORECASTS
ANZ: 1
TitleFY24
Actual
FY25
Actual
FY26
Forecast
FY27
Forecast
EPS (cps)xxx 198.2 245.2 xxx
DPS (cps)xxx 166.0 167.4 xxx
EPS Growthxxx - 9.1% 23.7% xxx
DPS Growthxxx 0.0% 0.8% xxx
PE Ratioxxx N/A 14.2 xxx
Dividend Yieldxxx N/A 4.8% xxx
Div Pay Ratio(%)xxx 83.8% 68.3% xxx

FOLLOW US ON SOCIAL MEDIA

9K Followers
25.7K Posts
@Filapek
Rudi Filapek-Vandyck@Filapek
8h
Is this what a market with low confidence looks like? Asking for a friend 😉
@Filapek
Rudi Filapek-Vandyck@Filapek
11h
RBC Capital on Ramsay Health Care $RHC: "The company has reaffirmed its outlook for the Australian business to achieve EBIT growth in FY26, however the 1Q performance of the Australian business is exceeding consensus revenue and EBIT growth expectations. "The company has
@Filapek
Rudi Filapek-Vandyck@Filapek
11h
RBC Capital on Web Travel Group $WEB: Overall a good result from WEB - ahead of consensus, in-line with RBCe. "The market should be pleased to see 1H26 TTV margin of 6.5% above guide of 6.2%-6.4%. "We note FY26 guidance of 6.5% suggests flat h/h margins vs prior guidance
@Filapek
Rudi Filapek-Vandyck@Filapek
12h
Markets are changing. All the time. But most definitely in our day and age. That raises questions. Some valid ones too. Do we have the answers? https://t.co/ZuhPRGHpcH
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
Picked this up from LinkedIn: "The narrative that AI is in a bubble is now so ubiquitous, that even a "how to invest" short on YouTube will warn you that you need to diversify away from impending doom."#investing#equities#XJO#stocks
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
Citi on Reece $REH: "Overall in line result, however the composition was interesting. "The ~15 stores or +4% non-organic sales contribution was higher than expected and may reduce concerns about management confidence in the roll-out strategy. "Additionally US LFL sales
@Filapek
Rudi Filapek-Vandyck@Filapek
1d
RBC Capital on Kogan $KGN: "We have updated our model to incorporate KGN's AGM trading update. The update showed weaker-than-expected top line growth and profitability, driven by the impact of technical challenges and an inventory right-sizing for Mighty Ape. "Both are now
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
RBC Capital on Kogan $KGN: "KGN's 1H26 trading update disappointed expectations at the group level with sales and margins tracking behind RBCe and consensus expectations. "However, while the headline result was off, we note weaker than expected performance was predominately
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
This looks like more nasty price action ahead: "Reports from bank flow desks also detail that systematic momentum/trend strategies have around $65B of equity to sell over the coming week, and $220B to sell in December, and that can't sit well with the would-be buyers. "Rising
@Filapek
Rudi Filapek-Vandyck@Filapek
4d
RBC Capital on Accent Group $AX1: "A very soft update from AX1 which includes a large downgrade to guidance - both for 1H26 and 2H26. "On a full year basis, today's guidance represents a 23% downgrade to consensus expectations. The business continues to be impacted by
FIND FNARENA ON

DAILY FINANCIAL NEWS

Picking A Lane: Car Platform Carma’s ASX Listing

Used car enterprise Carma listed earlier this month, raising $100m via its IPO

Nov 25 2025 - Small Caps


Michael Gable of Fairmont Equities notes 4DMedical shares retraced from a new October high and the bounce supports a move higher

Nov 25 2025 - Technicals


Nufarm posted a better than feared FY25 result, surprised by deciding to retain its Seeds business, and has optimistic growth targets for FY26

Nov 25 2025 - Small Caps


Shares in TechnologyOne reacted negatively on the release of a record FY25 performance, as not all metrics met elevated expectations and as the global technology sector is de-rated

Nov 24 2025 - Australia


Today’s EVs are the equivalent of last century’s Model T —a real game-changer— but for investors looking to profit, the challenges are plenty and real

Nov 24 2025 - Australia


Overviews in raw numbers and calculations that might assist investors with assessing trends and currents that might not be apparent from daily volatility and movements

Nov 22 2025 - Australia


rudi fnarena picture

RUDI'S VIEWS

Rudi’s View: Banks, Gold, Lithium & US Equities

JP Morgan has updated its 10-year outlook for global assets, while brokers line up their preferred exposures to lithium and gold, and among Aussie banks

Nov 20 2025

DAILY MARKET REPORTS

ASX Winners And Losers Of Today – 25-11-25

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 25 2025


The Overnight Report: Dec Rate Cut Hopes Rise

A global perspective on what happened overnight

Nov 25 2025


Today’s Financial Calendar – 25-11-2025

Significant Scheduled Events For 25 November, 2025

Nov 25 2025


ASX Winners And Losers Of Today – 24-11-25

The table inside ranks the 20 biggest percentage winners and losers among stocks in the ASX300 at the end of each trading day

Nov 24 2025


Australian Broker Call *Extra* Edition – Nov 24, 2025

Extra Edition of the Broker Call Report

Nov 24 2025


The Monday Report – 24 November 2025

Wrap of events affecting the market on Friday night and the weekend and a preview of the week ahead

Nov 24 2025


Today’s Financial Calendar – 24-11-2025

Significant Scheduled Events For 24 November, 2025

Nov 24 2025


WEEKLY REPORTS

Weekly Update On LICs & LITs – 25-Nov-2025

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 25 2025

Uranium Week: Geo-Politics & Japan’s Restart

Conflicting reports on US/Russia sanctions saw spot prices retreat on hopes of a Ukraine/Russia peace deal

Nov 25 2025

Australian Listed Real Estate Tables – 24-11-2025

FNArena provides a weekly update of Australian listed real estate trusts (REIT) and property developers, current pricing yield and valuation data

Nov 24 2025


Weekly Ratings, Targets, Forecast Changes – 21-11-25

Weekly update on stockbroker recommendation, target price, and earnings forecast changes

Nov 24 2025

Next Week At A Glance – 24-29 Nov 2025

A brief look at important company events and economic data releases next week

Nov 21 2025

Weekly Top Ten News Stories – 21 November 2025

Our top ten news stories from 13 November 2025 to 20 November 2025

Nov 21 2025


In Case You Missed It – BC Extra Upgrades & Downgrades – 21-11-25

A summary of the highlights from Broker Call Extra updates throughout the week past

Nov 21 2025

In Brief: Acrow, James Hardie & Pro Medicus

Three companies with appealing investment cases where share prices have been oversold or derated, offering investors another bite of the cherry

Nov 21 2025

The Short Report – 20 Nov 2025

FNArena’s weekly update on short positions in the Australian share market

Nov 20 2025


9K Followers
25.7K Posts
@Filapek
Rudi Filapek-Vandyck @Filapek
19h
Is this what a market with low confidence looks like? Asking for a friend 😉
@Filapek
Rudi Filapek-Vandyck @Filapek
22h
RBC Capital on Ramsay Health Care $RHC: "The company has reaffirmed its outlook for the Australian business to achieve EBIT growth in FY26, however the 1Q performance of the Australian business is exceeding consensus revenue and EBIT growth expectations. "The company has
@Filapek
Rudi Filapek-Vandyck @Filapek
22h
RBC Capital on Web Travel Group $WEB: Overall a good result from WEB - ahead of consensus, in-line with RBCe. "The market should be pleased to see 1H26 TTV margin of 6.5% above guide of 6.2%-6.4%. "We note FY26 guidance of 6.5% suggests flat h/h margins vs prior guidance
@Filapek
Rudi Filapek-Vandyck @Filapek
23h
Markets are changing. All the time. But most definitely in our day and age. That raises questions. Some valid ones too. Do we have the answers? https://t.co/ZuhPRGHpcH
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Picked this up from LinkedIn: "The narrative that AI is in a bubble is now so ubiquitous, that even a "how to invest" short on YouTube will warn you that you need to diversify away from impending doom." #investing #equities #XJO #stocks
@Filapek
Rudi Filapek-Vandyck @Filapek
1d
Citi on Reece $REH: "Overall in line result, however the composition was interesting. "The ~15 stores or +4% non-organic sales contribution was higher than expected and may reduce concerns about management confidence in the roll-out strategy. "Additionally US LFL sales
@Filapek
Rudi Filapek-Vandyck @Filapek
2d
RBC Capital on Kogan $KGN: "We have updated our model to incorporate KGN's AGM trading update. The update showed weaker-than-expected top line growth and profitability, driven by the impact of technical challenges and an inventory right-sizing for Mighty Ape. "Both are now
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
RBC Capital on Kogan $KGN: "KGN's 1H26 trading update disappointed expectations at the group level with sales and margins tracking behind RBCe and consensus expectations. "However, while the headline result was off, we note weaker than expected performance was predominately
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
This looks like more nasty price action ahead: "Reports from bank flow desks also detail that systematic momentum/trend strategies have around $65B of equity to sell over the coming week, and $220B to sell in December, and that can't sit well with the would-be buyers. "Rising
@Filapek
Rudi Filapek-Vandyck @Filapek
4d
RBC Capital on Accent Group $AX1: "A very soft update from AX1 which includes a large downgrade to guidance - both for 1H26 and 2H26. "On a full year basis, today's guidance represents a 23% downgrade to consensus expectations. The business continues to be impacted by
FIND FNARENA ON

THE MARKETS

    Click item/line to change chart

  • Australia

    26 November 2025   Updated : 07:12   AEDT

    SPI Overnight

    8573.00

    +36.00

    0.42%

    NZ50

    13480.430

    -19.420

    -0.140%

    All Ordinaries

    8824.20

    +23.80

    0.27%

    S&P ASX 200

    8537.00

    +11.90

    0.14%

    S&P ASX 300

    8491.50

    +16.50

    0.19%

    Communication Services

    1802.60

    -2.60

    -0.14%

    Consumer Discretionary

    4012.20

    -15.40

    -0.38%

    Consumer Staples

    11708.00

    -65.30

    -0.55%

    Energy

    8627.90

    +54.00

    0.63%

    Financials

    9014.20

    -60.70

    -0.67%

    Health Care

    35579.70

    +81.50

    0.23%

    Industrials

    8491.50

    +23.50

    0.28%

    Info Technology

    2317.60

    +27.50

    1.20%

    Materials

    19507.30

    +326.60

    1.70%

    Real Estate

    3908.30

    -20.60

    -0.52%

    Utilities

    9823.70

    -49.60

    -0.50%

    A-REITs

    1797.20

    -10.10

    -0.56%

    All Technology Index

    3605.10

    +27.50

    0.77%

    Banks

    3898.10

    -22.30

    -0.57%

    Gold Index

    17039.30

    +566.20

    3.44%

    Metals & Mining

    6665.00

    +127.20

    1.95%

    Click item/line to change chart

  • Australasia

    26 November 2025   Updated : 07:12   AEDT

    AUD/USD

    0.6474

    +0.00

    0.33%

    AUD/NZD

    1.1510

    0.00

    -0.16%

    NZD/USD

    0.5624

    +0.00

    0.46%

    AUD/JPY

    100.92

    -0.02

    -0.02%

    SGD/AUD

    1.19

    0.00

    -0.09%

    AUD/EUR

    0.5591

    0.00

    -0.13%

    AUD/GBP

    0.4901

    0.00

    -0.41%

    AUDCAD

    0.9123

    +0.00

    0.13%

  • World

    26 November 2025   Updated : 07:12   AEDT

    CAD/USD

    0.7096

    +0.00

    0.20%

    EUR/JPY

    180.52

    +0.20

    0.11%

    EUR/USD

    1.1580

    +0.01

    0.46%

    GBP/USD

    1.3210

    +0.01

    0.73%

    USD/JPY

    155.90

    -0.53

    -0.34%

    Click item/line to change chart

  • World

    26 November 2025   Updated : 07:12   AEDT

    FTSE100

    9609.53

    +74.62

    0.78%

    DAX30

    23464.63

    +225.45

    0.97%

    Hang Seng

    25894.55

    +178.05

    0.69%

    Nikkei 225

    48659.52

    +33.64

    0.07%

    DJIA

    47108.79

    +660.52

    1.42%

    S&P500

    6760.70

    +55.58

    0.83%

    Nasdaq Comp

    22984.20

    +112.20

    0.49%

    S&P500 VIX

    18.85

    -1.67

    -8.14%

    US 10-year yield

    4.002

    -0.036

    -0.890%

    USD Index

    100.10

    -0.01

    -0.01%

  • Aus Stocks

    26 November 2025   Updated : 07:12   AEDT

    Amcor (US)

    8.55

    +0.07

    0.83%

    Newmont (US)

    86.68

    +0.15

    0.17%

    Rio Tinto (UK)

    5404.00

    +49.00

    0.92%

    BHP Group (US)

    53.95

    +1.02

    1.93%

    Rio Tinto (US)

    71.40

    +0.92

    1.31%

    ResMed (US)

    256.43

    +5.91

    2.36%

    South32 (UK)

    155.20

    +0.80

    0.52%

    James Hardie (US)

    19.09

    +0.46

    2.47%

    Janus Henderson (US)

    42.65

    -0.42

    -0.98%

    Click item/line to change chart

  • Metals & Minerals

    25 November 2025   Updated : 08:16   AEDT

    Gold (oz)

    4166.70

    +50.70

    1.23%

    Silver (oz)

    51.18

    +1.26

    2.53%

    Copper (lb)

    5.0788

    -0.02

    -0.42%

    Aluminium (lb)

    1.2772

    +0.00

    0.33%

    Nickel (lb)

    6.4775

    0.00

    -0.02%

    Zinc (lb)

    1.3621

    +0.00

    0.31%

    Copper (t)

    11223.87

    -16.53

    -0.15%

    Aluminium (t)

    2814.85

    +9.15

    0.33%

    Nickel (t)

    14276.50

    -3.50

    -0.02%

    Zinc (t)

    3002.10

    +9.30

    0.31%

    Uranium (lb) weekly

    75.60

    -1.30

    -1.69%

    Iron Ore (t)

    104.42

    +0.16

    0.15%

  • Energy

    25 November 2025   Updated : 08:16   AEDT

    West Texas Crude

    58.95

    +1.14

    1.97%

    Brent Crude

    62.79

    +0.85

    1.37%

CALENDAR

Wednesday, 26 November 2025
NZ RBNZ OCR Decision
AU 3Q Construction Work
AU Oct CPI
US Advance Sept Durable Goods
US Fed Beige Book
US Weekly Jobless Claims
ALQex-div 19.4c (30%)
ARTAGM
ARTInvestor Day
ASLAGM
ASNAGM
B4PAGM
BIOAGM

ALL WEATHER STOCKS

CodeCompanyPrice
CARCAR GROUP LIMITED

market icon up$33.69

REAREA GROUP LIMITED

market icon up$201.80

RMDRESMED INC

market icon down$38.52

TNETECHNOLOGY ONE LIMITED

market icon up$30.58

WOWWOOLWORTHS GROUP LIMITED

market icon down$27.95

WEEKLY PDF

Stories To Read From FNArena


WEEK 47
locked icon

WEEK 46
icon pdf

WEEK 45
icon pdf

WEEK 44
icon pdf

WEEK 43
icon pdf

FNARENA TALKS

FNARENA WINDOWS

Window on AUTOMOBILES & COMPONENTS

Picking A Lane: Car Platform Carma’s ASX Listing

Used car enterprise Carma listed earlier this month, raising $100m via its IPO

Nov 25 2025


Window on WEALTH MANAGEMENT & INVESTMENTS

Weekly Update On LICs & LITs – 25-Nov-2025

Weekly update of Listed Investment Companies (LICs) & Listed Investment Trusts (LITs) on the ASX

Nov 25 2025


Window on MEDICAL EQUIPMENT & DEVICES

4DMedical Poised For A Recovery

Michael Gable of Fairmont Equities notes 4DMedical shares retraced from a new October high and the bounce supports a move higher

Nov 25 2025


GEN AI

AI’s Growth Meets Costs, Scale And Bottlenecks

Artificial intelligence is the most significant change to humanity in the 21st Century but the complexity, scale and needs for the technology create both opportunities and risks

Nov 20 2025


FEATURE STORIES

Australian Banks: Results Season Preview

Back in May, analysts declared Australian banks overvalued. Share prices outperformed since. Heading into the November season, analysts declare banks overvalued

Oct 30 2025